Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus who were, or were not, on antihyperglycaemic agents at screening

被引：0
|
作者：
Gonzalez-Galvez, G. [1 ]
Jodar, E. [2 ]
Kim, K. [3 ]
Alba, M. [4 ]
Tong, C. [4 ]
Meininger, G. [4 ]
机构：
[1] Inst Jalisciense Invest Diabet & Obesidad, Guadalajara, Jalisco, Mexico
[2] Hosp Quiron, Dept Endocrinol, Madrid, Spain
[3] Dongguk Univ, Sch Med, Ilsan Hosp, Dept Internal Med, Goyang, South Korea
[4] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
853
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [1] Effect of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) Who Were, or Were Not, on Antihyperglycemic Agents (AHAs) at Screening
    Gonzalez-Galvez, Guillermo
    Kim, Kyoung-Ah
    Jodar, Esteban
    Alba, Maria
    Tong, Cindy
    Meininger, Gary
    [J]. DIABETES, 2014, 63 : A280 - A280
  • [2] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM INDIA
    Kumar, K. M. Prasanna
    Mohan, V.
    Sethi, B.
    Gandhi, P.
    Bantwal, G.
    Xie, J.
    Meininger, G.
    Qiu, R.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S260 - S261
  • [3] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America
    Lavalle-Gonzalez, Fernando J.
    Eliaschewitz, Freddy G.
    Cerdas, Sonia
    Del Pilar Chacon, Maria
    Tong, Cindy
    Alba, Maria
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (03) : 427 - 439
  • [4] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
    John, M.
    Violante, R.
    Deerochanawong, C.
    Vijapurkar, U.
    Canovatchel, W.
    Hamilton, G.
    [J]. DIABETOLOGIA, 2015, 58 : S363 - S363
  • [5] CANAGLIFLOZIN ADDED ON TO ALPHA-GLUCOSIDASE INHIBITORS WITH OR WITHOUT OTHER ANTIHYPERGLYCAEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Fulcher, G.
    Tan, A.
    Shaw, W.
    Desai, M.
    Vijapurkar, U.
    Meininger, G.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S258 - S258
  • [6] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
    John, Mathew
    Cerdas, Sonia
    Violante, Rafael
    Deerochanawong, Chaicharn
    Hassanein, Mohamed
    Slee, April
    Canovatchel, William
    Hamilton, Gill
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2016, 70 (09) : 775 - 785
  • [7] The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus
    Gavin, James R., III
    Davies, Melanie J.
    Davies, Michael
    Vijapurkar, Ujjwala
    Alba, Maria
    Meininger, Gary
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1693 - 1702
  • [8] Oral antihyperglycaemic agents in type 2 diabetes mellitus
    Smith, Haley
    [J]. SA PHARMACEUTICAL JOURNAL, 2014, 81 (03) : 10 - 14
  • [9] Efficacy and safety of canagliflozin in older subjects with type 2 diabetes mellitus
    Sinclair, A.
    Bode, B.
    Harris, S.
    Vijapurkar, U.
    Gassmann-Mayer, C.
    Fung, A.
    Shaw, W.
    Usiskin, K.
    Desai, M.
    Meininger, G.
    [J]. DIABETOLOGIA, 2013, 56 : S383 - S383
  • [10] An Efficacy and Safety Study of Remogliflozin in Obese Indian Type 2 Diabetes Mellitus Patients Who Were Inadequately Controlled on Insulin Glargine Plus other Oral Hypoglycemic Agents
    Shankar, Anand
    [J]. CURRENT DIABETES REVIEWS, 2021, 17 (07)
12345